FA Renal Flashcards
Osmotic diuretic in the PCT, increased tubular fluid osmolarity, producing increased urine flow, decreased intracranial/ intraocular pressure.
Mannitol
Carbonic anhydrase inhibitor in PCT. Causes self limited NaHC03 diuresis and reduction in total-body HC03- stores.
Acetazolamide
Sulfonamide loop diuretic.
Inhibits cotransport system (Na+, K+, 2 Cl-) of thick ascending limb of loop of Henle.
Abolishes hypertonicity of medulla, preventing concentration of urine. Stimulates PGE release (vasodilatory effect on afferent arteriole); inhibited by NSAIDs. Increased Ca2+ excretion.
Loop diuretic (furosemide)
Phenoxyacetic acid derivative (not a sulfonamide). Inhibits cotransport system (Na+, K+, 2 Cl-) of thick ascending limb of loop of Henle.
Ethacrynic acid
Inhibits NaCl reabsorption in early DCT, reducing diluting capacity of the nephron. Decreased Ca2+ excretion.
Hydrochlorothiazide
Competitive aldosterone receptor antagonists in the cortical collecting tubule.
Spironolactone
Eplerenone
Block Na+ channels in the CCT.
Amiloride
Triamterene
Mannitol clinical use
Drug overdose,
elevated intracranial/intraocular pressure.
Acetazolamide clinical use
Glaucoma, urinary alkalinization, metabolic alkalosis, altitude sickness, pseudotumor cerebri (idiopathic intracranial HTN)
Furosemide clinical use
Edematous states (CHF, cirrhosis, nephrotic syndrome, pulmonary edema),
hypertension,
hypercalcemia.
Hydrochlorothiazide clinical use
Hypertension,
CHF,
idiopathic hypercalciuria,
nephrogenic diabetes insipidus.
K+-sparing diuretic clinical use
Hyperaldosteronism,
K+ depletion,
CHF.
Ethacrynic acid clinical use
Diuresis in patients allergic to sulfa drugs.
Pulmonary edema,
Dehydration.
Contraindicated in anuria, CHF.
Mannitol toxicity
Hyperchloremic metabolic acidosis, Hypokalemia, NH3 toxicity, Neuropathy (paresthesias), Sulfa allergy.
Acetazolamide toxicity